Your browser doesn't support javascript.
loading
Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocol.
Ben Khaled, Najib; Seidensticker, Max; Ricke, Jens; Mayerle, Julia; Oehrle, Bettina; Rössler, Daniel; Teupser, Daniel; Ehmer, Ursula; Bitzer, Michael; Waldschmidt, Dirk; Fuchs, Martin; Reuken, Philipp A; Lange, Christian M; Wege, Henning; Kandulski, Arne; Dechêne, Alexander; Venerito, Marino; Berres, Marie-Luise; Luedde, Tom; Kubisch, Ilja; Reiter, Florian P; De Toni, Enrico N.
Afiliação
  • Ben Khaled N; Department of Medicine II, University Hospital, LMU Munich, Munich, 81377, Germany.
  • Seidensticker M; Department of Radiology, University Hospital, LMU Munich, Munich, 81377, Germany.
  • Ricke J; Department of Radiology, University Hospital, LMU Munich, Munich, 81377, Germany.
  • Mayerle J; Department of Medicine II, University Hospital, LMU Munich, Munich, 81377, Germany.
  • Oehrle B; Department of Medicine II, University Hospital, LMU Munich, Munich, 81377, Germany.
  • Rössler D; Department of Medicine II, University Hospital, LMU Munich, Munich, 81377, Germany.
  • Teupser D; Institute of Laboratory Medicine, University Hospital, LMU Munich, Munich, 81377, Germany.
  • Ehmer U; Internal Medicine II, Klinikum rechts der Isar, TU München, Munich, 81675, Germany.
  • Bitzer M; Department for Internal Medicine I & Center for Personalized Medicine, Eberhard-Karls University, Tübingen, 72016, Germany.
  • Waldschmidt D; Department of Gastroenterology, University Hospital of Cologne, Cologne, 50937, Germany.
  • Fuchs M; Department of Gastroenterology, Hepatology & GI-Oncology, Munich Hospital Bogenhausen, Munich, 81925, Germany.
  • Reuken PA; Department of Internal Medicine IV, Jena University Hospital, Jena, 07743, Germany.
  • Lange CM; Department of Medicine II, University Hospital, LMU Munich, Munich, 81377, Germany.
  • Wege H; Department of Gastroenterology & Hepatology, University Hospital Essen, Essen, 45147, Germany.
  • Kandulski A; Cancer Center Esslingen, Medical Center Esslingen, Esslingen, 73730, Germany.
  • Dechêne A; Department of Gastroenterology, University Hospital Regensburg, Regensburg, 93053, Germany.
  • Venerito M; Department of Gastroenterology, Hepatology & Endocrinology, General Hospital Nuremberg, Nuremberg, 90419, Germany.
  • Berres ML; Department of Gastroenterology, Hepatology & Infectious Diseases, Otto-von-Guericke University Hospital, Magdeburg, 39120, Germany.
  • Luedde T; Medical Department III, University Hospital of Aachen, Aachen, 52074, Germany.
  • Kubisch I; Clinic for Gastroenterology, Hepatology & Infectious Diseases, University Hospital of Düsseldorf, Düsseldorf, 40225, Germany.
  • Reiter FP; Department of Internal Medicine II, Gastroenterology, Hepatology, Endocrinology, Metabolic Disorders, Oncology, Klinikum Chemnitz gGmbH, Chemnitz, 09116, Germany.
  • De Toni EN; Division of Hepatology, Department of Medicine II, University Hospital Würzburg, Würzburg, 97080, Germany.
Future Oncol ; 18(12): 1423-1435, 2022 04.
Article em En | MEDLINE | ID: mdl-35081747
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quimioembolização Terapêutica / Carcinoma Hepatocelular / Anticorpos Monoclonais Humanizados / Bevacizumab / Neoplasias Hepáticas Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quimioembolização Terapêutica / Carcinoma Hepatocelular / Anticorpos Monoclonais Humanizados / Bevacizumab / Neoplasias Hepáticas Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article